Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mitochondrial Dysfunction in Chronic Kidney Disease

Trial Profile

Mitochondrial Dysfunction in Chronic Kidney Disease

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Icatibant (Primary)
  • Indications Mitochondrial disorders
  • Focus Therapeutic Use
  • Acronyms MitoCKD
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Aug 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 08 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top